CNMD CONMED Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CNMD

Price (delayed)

$101.02

Market cap

$3.08B

P/E Ratio

N/A

Dividend/share

$0.8

EPS

-$2.68

Enterprise value

$4.11B

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, ...

Highlights
CNMD's EPS is up by 4.3% QoQ
The net income is up by 2.6% since the previous quarter
CNMD's equity is down by 5% YoY but it is up by 4.1% from the previous quarter
CNMD's revenue is up by 3.4% year-on-year but it is down by 2.2% since the previous quarter
The company's debt has surged by 54% YoY
CNMD's quick ratio is down by 33% QoQ and by 29% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.conmed.com
Peers: BSX MDT TFX IART

Key stats

What are the main financial stats of CNMD
Market
Shares outstanding
30.5M
Market cap
$3.08B
Enterprise value
$4.11B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.13
Price to sales (P/S)
2.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.93
Earnings
Revenue
$1.05B
EBIT
-$41.96M
EBITDA
-$25.9M
Free cash flow
$11.58M
Per share
EPS
-$2.68
Free cash flow per share
$0.38
Book value per share
$24.46
Revenue per share
$34.3
TBVPS
$26.26
Balance sheet
Total assets
$2.3B
Total liabilities
$1.55B
Debt
$1.05B
Equity
$745.55M
Working capital
$284.67M
Liquidity
Debt to equity
1.41
Current ratio
1.96
Quick ratio
0.74
Net debt/EBITDA
-39.61
Margins
EBITDA margin
-2.5%
Gross margin
54.6%
Net margin
-7.7%
Operating margin
-4%
Efficiency
Return on assets
-3.8%
Return on equity
-11%
Return on invested capital
-2.9%
Return on capital employed
-2.1%
Return on sales
-4%
Dividend
Dividend yield
0.79%
DPS
$0.8
Payout ratio
N/A

CNMD stock price

How has the CONMED stock price performed over time
Intraday
4.14%
1 week
8.26%
1 month
6.78%
1 year
-30.17%
YTD
13.97%
QTD
13.97%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.05B
Gross profit
$571.25M
Operating income
-$41.96M
Net income
-$80.58M
Gross margin
54.6%
Net margin
-7.7%
The operating income has dropped by 139% year-on-year
The operating margin has dropped by 137% year-on-year
CONMED's gross profit has decreased by 4% QoQ
The net income is up by 2.6% since the previous quarter

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
P/E
N/A
P/B
4.13
P/S
2.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.93
CNMD's EPS is up by 4.3% QoQ
The stock's price to book (P/B) is 6% more than its 5-year quarterly average of 3.9
CNMD's equity is down by 5% YoY but it is up by 4.1% from the previous quarter
CNMD's revenue is up by 3.4% year-on-year but it is down by 2.2% since the previous quarter

Efficiency

How efficient is CONMED business performance
CNMD's ROS has shrunk by 137% YoY
CNMD's return on invested capital has dropped by 131% year-on-year
CNMD's return on assets is up by 10% since the previous quarter

Dividends

What is CNMD's dividend history
Dividend details
DPS
$0.8
Dividend yield
0.79%
Payout ratio
N/A
Recent dividends

Financial health

How did CONMED financials performed over time
CNMD's total assets is 48% greater than its total liabilities
The total liabilities has surged by 58% year-on-year
CNMD's quick ratio is down by 33% QoQ and by 29% YoY
The company's debt is 41% higher than its equity
The company's debt to equity has surged by 62% YoY but it fell by 2.8% QoQ
The company's debt has surged by 54% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.